Spots Global Cancer Trial Database for sabr
Every month we try and update this database with for sabr cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer | NCT03159676 | Prostate Cancer | Proton beam | 18 Years - | Mayo Clinic | |
| Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) | NCT05817604 | Kidney Neoplasm Renal Cancer Inoperable Dise... SBRT SABR | SBRT | 18 Years - 100 Years | Consorci Sanitari de Terrassa | |
| Low and Intermediate Risk oliGometastatic coloREctal cancEr patieNts Treated With Stereotactic ABlative Radiotherapy | NCT06310564 | Colorectal Canc... | SABR | 18 Years - | IRCCS Sacro Cuore Don Calabria di Negrar | |
| Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC | NCT04786093 | Non Small Cell ... | Stereotactic ra... Durvalumab | 18 Years - | University of Texas Southwestern Medical Center | |
| Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC | NCT05277844 | Oligometastatic... Non-small Cell ... Driver Mutation | Local Consolida... TKI | 18 Years - 99 Years | Tata Memorial Hospital | |
| Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm. | NCT01933568 | Inoperable Loca... | SABR Cisplatin | 18 Years - | The Netherlands Cancer Institute | |
| Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours | NCT02992912 | Patients With M... | Anti-PD-L1 anti... SABR | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| Combining SBRT and Immunotherapy in Early Stage NSCLC Patients Planned for Surgery | NCT03446911 | NSCLC, Stage I | SABR SABR + pembroli... | 18 Years - | Amsterdam UMC, location VUmc | |
| Low and Intermediate Risk oliGometastatic coloREctal cancEr patieNts Treated With Stereotactic ABlative Radiotherapy | NCT06310564 | Colorectal Canc... | SABR | 18 Years - | IRCCS Sacro Cuore Don Calabria di Negrar | |
| Stereotactic Ablative Radiation Therapy for Prostate Cancer | NCT05668351 | Prostate Cancer | SUPR-SABR treat... | 18 Years - | Medical University of South Carolina | |
| SOFT- Stereotactic Ablative Radiotherapy of Infra-diaphragmatic Soft Tissue Metastases | NCT04407897 | Solid Tumor Oligometastases Soft Tissue Dis... | Stereotactic ra... | 18 Years - 99 Years | Herlev Hospital | |
| Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) | NCT05817604 | Kidney Neoplasm Renal Cancer Inoperable Dise... SBRT SABR | SBRT | 18 Years - 100 Years | Consorci Sanitari de Terrassa | |
| Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy | NCT02357992 | Lung Cancer | Stereotactic Bo... | 18 Years - | M.D. Anderson Cancer Center | |
| SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients | NCT03126461 | Melanoma Metastatic Mela... | SAbR Ipilimumab Nivolumab | 18 Years - 99 Years | University of Texas Southwestern Medical Center | |
| Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma | NCT02781506 | Metastatic Clea... | Nivolumab SAbR | 18 Years - 100 Years | University of Texas Southwestern Medical Center | |
| Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) | NCT05817604 | Kidney Neoplasm Renal Cancer Inoperable Dise... SBRT SABR | SBRT | 18 Years - 100 Years | Consorci Sanitari de Terrassa | |
| Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) | NCT05817604 | Kidney Neoplasm Renal Cancer Inoperable Dise... SBRT SABR | SBRT | 18 Years - 100 Years | Consorci Sanitari de Terrassa | |
| Durvalumab vs Placebo With Stereotactic Body Radiation Therapy in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients / Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation | NCT03833154 | Carcinoma, Non-... | Durvalumab Placebo Osimertinib (si... | 18 Years - 130 Years | AstraZeneca | |
| Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate Cancer | NCT02016248 | Prostate Cancer | Stereotactic Ab... Stereotactic Ab... | 18 Years - | MemorialCare Health System | |
| Durvalumab vs Placebo With Stereotactic Body Radiation Therapy in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients / Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation | NCT03833154 | Carcinoma, Non-... | Durvalumab Placebo Osimertinib (si... | 18 Years - 130 Years | AstraZeneca | |
| Ablative Radiotherapy to Consolidate Maximal Systemic Response in Metastatic Prostate Cancer (ANCHOR-Prostate) | NCT05457699 | Prostate Cancer... | SABR no RT | - | Centre hospitalier de l'Université de Montréal (CHUM) | |
| Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer | NCT04405401 | Lung Cancer Met... | SABR Standard of car... | 18 Years - | Centre hospitalier de l'Université de Montréal (CHUM) | |
| SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients | NCT03126461 | Melanoma Metastatic Mela... | SAbR Ipilimumab Nivolumab | 18 Years - 99 Years | University of Texas Southwestern Medical Center | |
| NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy | NCT03589339 | Radiotherapy Immunotherapy Microsatellite ... Metastasis From... Squamous Cell C... Metastasis From... Metastatic Rena... Metastasis From... Metastatic Trip... Metastatic NSCL... Metastasis From... | NBTXR3 SABR Nivolumab Pembrolizumab | 18 Years - | Nanobiotix | |
| Prostate PMSABR Study | NCT04742972 | Prostate Cancer | SABR SOC | 18 Years - | Chinese University of Hong Kong | |
| Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer | NCT05377047 | Breast Cancer S... Oligometastatic... | SABR | 18 Years - | Vastra Gotaland Region | |
| Combining SBRT and Immunotherapy in Early Stage NSCLC Patients Planned for Surgery | NCT03446911 | NSCLC, Stage I | SABR SABR + pembroli... | 18 Years - | Amsterdam UMC, location VUmc | |
| Study of Osimertinib and Stereotactic Ablative Radiation (SABR) in EGFR Mutant NSCLC | NCT03667820 | Non-small Cell ... | Osimertinib SABR | 18 Years - 99 Years | University of Texas Southwestern Medical Center | |
| Standard Maintenance Therapy (SMT) vs Local Consolidative Radiation Therapy and SMT in OM-NSCLC | NCT05278052 | Oligometastatic... Metastatic Non ... | Local consolida... Standard mainte... | 18 Years - 99 Years | Tata Memorial Hospital | |
| Stereotactic MRI-Guided Radiation for Localized Prostate Cancer | NCT03588819 | Prostate Cancer | SABR | 18 Years - | Sunnybrook Health Sciences Centre | |
| Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer | NCT03464942 | Breast Cancer | SABR Atezolizumab | 18 Years - 70 Years | Peter MacCallum Cancer Centre, Australia | |
| A Randomized Phase II Study of Stereotactic Ablative Body Radiotherapy for Metastases to the Lung (TROG 13.01 SAFRON II) | NCT01965223 | Cancer Metastases to t... | Multi-fraction ... Single Fraction... | 18 Years - | Trans Tasman Radiation Oncology Group | |
| Stereotactic MRI-Guided Radiation for Localized Prostate Cancer | NCT03588819 | Prostate Cancer | SABR | 18 Years - | Sunnybrook Health Sciences Centre | |
| Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC | NCT05277844 | Oligometastatic... Non-small Cell ... Driver Mutation | Local Consolida... TKI | 18 Years - 99 Years | Tata Memorial Hospital | |
| Prostate PMSABR Study | NCT04742972 | Prostate Cancer | SABR SOC | 18 Years - | Chinese University of Hong Kong | |
| Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney | NCT02613819 | Renal Cell Carc... | SABR | 18 Years - | Trans Tasman Radiation Oncology Group | |
| NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy | NCT03589339 | Radiotherapy Immunotherapy Microsatellite ... Metastasis From... Squamous Cell C... Metastasis From... Metastatic Rena... Metastasis From... Metastatic Trip... Metastatic NSCL... Metastasis From... | NBTXR3 SABR Nivolumab Pembrolizumab | 18 Years - | Nanobiotix | |
| UroLift System With SAbR for Prostate Cancer and BPH | NCT05311527 | Prostate Cancer | Urolift SABR | 45 Years - | University of Texas Southwestern Medical Center | |
| The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance | NCT06117059 | Localized Prost... Low Risk Prosta... Intermediate Ri... | 3 fractions of ... | - | NHS Lothian | |
| Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy | NCT05169177 | Liver Neoplasm | 18 Years - | University of Sydney | ||
| Effect on Patient Reported Outcomes of VATS and SABR (LILAC) | NCT02882750 | Lung Cancer | EORTC QLQ-C30 (... PS Q18 Decision Self-E... | 18 Years - | University of Leeds | |
| Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy | NCT02357992 | Lung Cancer | Stereotactic Bo... | 18 Years - | M.D. Anderson Cancer Center | |
| The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance | NCT06117059 | Localized Prost... Low Risk Prosta... Intermediate Ri... | 3 fractions of ... | - | NHS Lothian |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
